Advanced Search
SU Han wen, LI Yan, XU Pu. The study of diagnosis of complexed prostate-specific antigen for prostate cancer[J]. Cancer Research on Prevention and Treatment, 2003, 30(03): 198-199. DOI: 10.3971/j.issn.1000-8578.2730
Citation: SU Han wen, LI Yan, XU Pu. The study of diagnosis of complexed prostate-specific antigen for prostate cancer[J]. Cancer Research on Prevention and Treatment, 2003, 30(03): 198-199. DOI: 10.3971/j.issn.1000-8578.2730
shu

The study of diagnosis of complexed prostate-specific antigen for prostate cancer

  • Department of Clinical Laboratory Science; Renmin Hospital of Wuhan University; Wuhan 430060; China

More Information
  • Corresponding author:

    SU Han wen

  • Received Date: October 27, 2002
  • Revised Date: February 10, 2003
    Graphical Abstract
    • Abstract
  • Objective To evaluate the clinical value of serum complex prostate-specific antigen(c PSA) for the diagnosis of prostate cancer. Methods Serum samples were obtained from 72 men with untreated benign prostatic hyperplasia (BPH) and 38 men with untreated prostate cancer. The levels of c PSA, t PSA were determined by using auto immuno chemistry luminescence method. Results When all subjects were detected both total PSA and the complex PSA and complex/total PSA ratio were significantly different between p...
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]LI Basen, LIU Liangjin, RUAN Yajun, TAN Fangqin, LI Qin, HAN Yunfeng. Evaluation of Therapeutic Response to Endocrine Therapy for Prostate Cancer by MRI Diffusion-weighted Imaging Based on PI-RADSv2.1[J]. Cancer Research on Prevention and Treatment, 2023, 50(7): 694-699. DOI: 10.3971/j.issn.1000-8578.2023.22.1396
    [2]ZENG Kai, LIU Jihong, LI Qiang, WANG Qinzhang. Research Progress of Lipid Metabolism Reprogramming in Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(8): 774-779. DOI: 10.3971/j.issn.1000-8578.2022.21.1546
    [3]LI Ning, XIAO Guoyou. Advances in Treatment of Patients with Prostate Cancer Bone Metastases[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 641-646. DOI: 10.3971/j.issn.1000-8578.2020.19.1141
    [4]ZHANG Qiang, SUN Lijiang, ZHANG Guiming, QI Jun, YANG Zhigang. Influence of Periprostatic Adiposity Measurement Parameters on Preoperative Staging and Grading of Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 488-491. DOI: 10.3971/j.issn.1000-8578.2018.17.1382
    [5]CHEN Lieqian, TAN Guobin, CHEN Hege, LIU Jianjun. Nitric Oxide-donor Drugs and Prostate Cancer: An Update[J]. Cancer Research on Prevention and Treatment, 2016, 43(2): 162-166. DOI: 10.3971/j.issn.1000-8578.2016.02.014
    [6]WANG Yiwei, GUO Jianming, WANG Guomin. Serologic Evidence in Early Detection of Bone Metastasis in Patients with Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(02): 102-106. DOI: 10.3971/j.issn.1000-8578.2014.02.002
    [7]WANG Zhenghua, ZHU Zhitu. Study on Combined Systemic Delivery of siRNA Specific to Tumor Mediated by Atelocollagen and Cisplatin against Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(04): 336-340. DOI: 10.3971/j.issn.1000-8578.2013.04.005
    [8]HUANG Yi, WANG Jun-jie, RAN Wei-qiang, MA Lu-lin, CHEN Zhong-xin. Permanent ~(125)Ⅰrostate Brachytherapy Combined with Castration for Clinical Stage C Prostate Cancer(Report of 10 Cases)[J]. Cancer Research on Prevention and Treatment, 2004, 31(12): 770-772. DOI: 10.3971/j.issn.1000-8578.1580
    [9]SHAO Yuan, ZHANG Zu-bao. PSAD and Free-to-Total PSA Ratio in Patients with Prostate Cancer or Benign Prostatic Hyperplasia[J]. Cancer Research on Prevention and Treatment, 2000, 27(01): 46-47. DOI: 10.3971/j.issn.1000-8578.2544
    [10]Xia Ji Rong, . Assay and Used of Prostate Spectisc Antigen[J]. Cancer Research on Prevention and Treatment, 1997, 24(1): 40-41.

Catalog

    Get Citation
    PDF
    XML
    Article views (2709) PDF downloads (693) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：18803015 Visits today：8805

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return